Evidence map›Paper›PMID 34411201›Full record

ArticlePLoS pathogens2021

Human cytomegalovirus blocks canonical TGFβ signaling during lytic infection to limit induction of type I interferons.

Andrew H Pham, Jennifer Mitchell, Sara Botto, Kara M Pryke, Victor R DeFilippis, Meaghan H Hancock

Abstract read
In one paragraph

Article in PLoS pathogens, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Human cytomegalovirus and neonatal infection.Current research in microbial sciences · 2024
    Review
  7. Viral miRNA regulation of host gene expression.Seminars in cell & developmental biology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Andrew H PhamVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.ORCID 0000-0002-9826-4826
Jennifer MitchellVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.ORCID 0000-0002-0323-2662
Sara BottoVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Kara M PrykeVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Victor R DeFilippisVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Meaghan H HancockVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.ORCID 0000-0003-2945-0147

Funding

The Administrative CoreP01AI127335 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI Patrizia Caposio · 2017 to 2026
$24.6M
Mechanistic Exploration of cGAS-STING-Mediated Vaccine EnhancementR01AI143660 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI DEFILIPPIS, VICTOR ROBERT · 2019 to 2023
$3.7M
NIAID NIH HHS P01 AI127335NIAID NIH HHS R01 AI143660
6 · The paper itself

Abstract

Human cytomegalovirus (HCMV) microRNAs (miRNAs) significantly rewire host signaling pathways to support the viral lifecycle and regulate host cell responses. Here we show that SMAD3 expression is regulated by HCMV miR-UL22A and contributes to the IRF7-mediated induction of type I IFNs and IFN-stimulated genes (ISGs) in human fibroblasts. Addition of exogenous TGFβ interferes with the replication of a miR-UL22A mutant virus in a SMAD3-dependent manner in wild type fibroblasts, but not in cells lacking IRF7, indicating that downregulation of SMAD3 expression to limit IFN induction is important for efficient lytic replication. These findings uncover a novel interplay between SMAD3 and innate immunity during HCMV infection and highlight the role of viral miRNAs in modulating these responses.

Indexed as

CytomegalovirusCytomegalovirus InfectionsFibroblastsHost-Pathogen InteractionsHumansImmunity, InnateInterferon Regulatory FactorsInterferon Type IMicroRNAsSmad3 ProteinTransforming Growth Factor betaVirus Physiological PhenomenaInterferon Regulatory FactorsInterferon Type IMicroRNAsSmad3 ProteinTransforming Growth Factor beta

Identifiers

PMID34411201
PMCPMC8407580

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.